It is currently known that a subset of patients with COVID-19 have a higher risk of bleeding, and high levels of tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor 1 (PAI- 1) have been associated with a worse lung function. This evidence concerns the gene PLAT and COVID-19.